Provided by Tiger Fintech (Singapore) Pte. Ltd.

TherapeuticsMD

1.12
-0.0500-4.27%
Pre-market: 1.180.0590+5.27%08:52 EDT
Volume:27.87K
Turnover:31.60K
Market Cap:12.96M
PE:-6.00
High:1.19
Open:1.18
Low:1.11
Close:1.17
Loading ...
Nov 08, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 06, 2019

Major Issues Report

Current report, items 2.02, 7.01, and 9.01
Oct 29, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Oct 24, 2019

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses
Oct 23, 2019

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses
Oct 23, 2019

Major Issues Report

Current report, items 2.02, 7.01, and 9.01
Oct 15, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Oct 01, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Sep 25, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Sep 16, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Sep 10, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Aug 19, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 15, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 14, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 14, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 12, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 09, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 06, 2019

Major Issues Report

Current report, items 2.02, 7.01, and 9.01